23andMe will start giving customers health data again after limited FDA approval

Almost two years after it was ordered to stop selling its DNA analysis service by the US Food and Drug Administration, genetic testing company 23andme is set to announce that it will once again provide its customers with health data, The New York Times reports. The company will now be able to offer users information about their "carrier status," informing them of the risk of passing 36 diseases and conditions (including sickle-cell anemia and cystic fybrosis) on to their children, based on sampl...